These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3318260)

  • 1. Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in man. A double-blind cross-over study.
    Jørgensen JO; Flyvbjerg A; Dinesen J; Lund H; Alberti KG; Orskov H; Christiansen JS
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):381-6. PubMed ID: 3318260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients.
    Jørgensen JO; Flyvbjerg A; Lauritzen T; Alberti KG; Orskov H; Christiansen JS
    J Clin Endocrinol Metab; 1988 Jul; 67(1):36-40. PubMed ID: 3288652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the lipolytic potencies of pituitary-derived and biosynthetic human growth hormone in hypopituitary children.
    Van Vliet G; Bosson D; Craen M; Du Caju MV; Malvaux P; Vanderschueren-Lodeweyckx M
    J Clin Endocrinol Metab; 1987 Nov; 65(5):876-9. PubMed ID: 3667884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.
    Beshyah SA; Henderson A; Niththyananthan R; Skinner E; Anyaoku V; Richmond W; Sharp P; Johnston DG
    J Clin Endocrinol Metab; 1995 Feb; 80(2):356-63. PubMed ID: 7852490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of subcutaneous and intramuscular administration of human growth hormone (hGH) and increased growth rate by daily injection of hGH in GH deficient children.
    Takano K; Shizume K; Hibi I
    Endocrinol Jpn; 1988 Jun; 35(3):477-84. PubMed ID: 3197659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of octreotide on insulin-like growth factor I and metabolic indices in growth hormone-treated growth hormone-deficient patients.
    Laursen T; Jørgensen JO; Orskov H; Møller J; Harris AG; Christiansen JS
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):399-408. PubMed ID: 7506470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children.
    Kaplan SL; Underwood LE; August GP; Bell JJ; Blethen SL; Blizzard RM; Brown DR; Foley TP; Hintz RL; Hopwood NJ
    Lancet; 1986 Mar; 1(8483):697-700. PubMed ID: 2870221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of growth and somatomedin C responses following growth hormone treatment in children with small-for-date short stature, significant idiopathic short stature and hypopituitarism.
    Grunt JA; Howard CP; Daughaday WH
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):168-74. PubMed ID: 6539552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site.
    Rosenfeld RG; Wilson DM; Dollar LA; Bennett A; Hintz RL
    J Clin Endocrinol Metab; 1982 May; 54(5):1033-8. PubMed ID: 7037819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa.
    Sizonenko PC; Rabinovitch A; Schneider P; Paunier L; Wollheim CB; Zahnd G
    Pediatr Res; 1975 Sep; 9(9):733-8. PubMed ID: 1105371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children.
    Van Vliet G; Bosson D; Robyn C; Craen M; Malvaux P; Vanderschueren-Lodeweyckx M; Wolter R
    Horm Res; 1985; 22(1-2):32-45. PubMed ID: 3928475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of human growth hormone administration on growth rate and growth-stimulating activity of serum, measured by lymphocyte bioassay in hypopituitary children.
    Bozzola M; Lorini R; Schimpff RM; Severi F; Job JC
    Horm Metab Res; 1986 Apr; 18(4):264-7. PubMed ID: 3710421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
    Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects.
    Ho KY; Weissberger AJ; Stuart MC; Day RO; Lazarus L
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):335-45. PubMed ID: 2598470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative potency of subtilisin-cleaved and intact human growth hormone measured in growth hormone-deficient human subjects.
    Bunner DL; Lewis UJ; Vanderlaan WP
    J Clin Endocrinol Metab; 1979 Feb; 48(2):293-6. PubMed ID: 429482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of subcutaneous and intramuscular administration of human growth hormone in the therapy of growth hormone deficiency.
    Russo L; Moore WV
    J Clin Endocrinol Metab; 1982 Nov; 55(5):1003-6. PubMed ID: 6889608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of various doses of biosynthetic growth hormone on levels of IGF-I binding protein 3 (IGFBP-3) in patients with hypopituitarism and growth hormone deficiency].
    Justová V; Lacinová Z; Marek J
    Sb Lek; 2002; 103(2):133-9. PubMed ID: 12688134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.
    Jørgensen JO; Møller N; Lauritzen T; Alberti KG; Orskov H; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jan; 70(1):207-14. PubMed ID: 2294131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.